Sort
82,697 grants matching “vaccine development”
Mechanisms of vaccine interference by S. aureus-induced imprints
$750,580George Y Liu · University Of California, San Diego · R01 · FY2024 · AI
Defending Against Systemic Mycoses
$750,578University Of Cincinnati · P01 · FY2005 · AI
Defining HIV reservoirs that rebound following suspension of ART
$750,560Lisa M Frenkel · Seattle Children'S Hospital · R01 · FY2018 · AI
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
$750,481Kathryn M Anastos · Albert Einstein College Of Medicine, Inc · U54 · FY2016 · CA
Developmental Core
$750,469Jonathan E Golub · Johns Hopkins University · P30 · FY2025 · AI
Duration of Hormonal Contraceptive Use: Immune Responses & Vaginal Microbiota
$750,468Khalil G Ghanem · Johns Hopkins University · R01 · FY2012 · AI
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
$750,461Susan C. Baker · Loyola University Chicago · R01 · FY2022 · AI
CTL Exclusion from Lymphoid Follicles as a Mechanism of Lentivirus Immune Invasio
$750,436Pamela J Skinner · University Of Minnesota · R56 · FY2010 · AI
Dissemination of the Cardiovascular Risk Service (CVRS Live)
$750,416Korey A Kennelty · University Of Iowa · R01 · FY2018 · HL
Project 3
$750,394J. Victor Garcia-Martinez · University Of Alabama At Birmingham · P01 · FY2025 · AI
HCMV Vaccine produced from BAC-MVA that Blocks Epithelial and Fibroblast Entry
$750,339Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2014 · AI
Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts
$750,333Timothy R Sterling · Vanderbilt University Medical Center · R01 · FY2023 · AI
Molecular-Targeted Radiation Therapy
$750,295C Norman Coleman · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Vaccine Efficacy of Modified HIV Envelopes
$750,287Leonidas A Stamatatos · Seattle Biomedical Research Institute · R01 · FY2009 · AI
Recurrence of Cholera in Haiti: Exploration of Contributing Factors and Intervention Strategies
$750,278John Glenn Morris · University Of Florida · R01 · FY2025 · AI
Recombinant Hyperimmune Gammaglobulin for Primary Immunodeficiency
$750,198David Scott Johnson · Gigagen, Inc. · R44 · FY2016 · AI
Fusion inhibitors that block host-to-host transmission of SARS-CoV-2
$750,151Matteo Porotto · Columbia University Health Sciences · R01 · FY2021 · AI
Evolution of anti-filovirus B cell responses and mechanisms of protection
$750,143M. Javad Aman · Integrated Biotherapeutics, Inc. · R01 · FY2018 · AI
Estimating Cholera Burden with Cross-sectional Immunologic Data
$750,105Daniel Ted Leung · University Of Utah · R01 · FY2018 · AI
Dynamics of the protective vaccine-induced human influenza neuraminidase B cell response
$750,079James J Kobie · University Of Alabama At Birmingham · R01 · FY2019 · AI
In Vivo And In Vitro Studies Of Hepatitis E Virus
$750,057Suzanne U Emerson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
St. Jude/Memphis IMPAACT Clinical Trials Unit (Composite)
$750,052Patricia Michele Flynn · St. Jude Children'S Research Hospital · U01 · FY2009 · AI
Synthesis of Antitumor Natural Products
$750,028Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R37 · FY2008 · CA
Characterization and Development of a Cross Spectrum Anti-Dengue Antibody
$750,000Ram Sasisekharan · Massachusetts Institute Of Technology · R01 · FY2018 · AI
IAS 2023, the 12th IAS Conference on HIV Science, Brisbane, Australia, and virtually, 23-26 July 2023
$750,000Chris Beyrer · Ias · R13 · FY2023 · AI